​

Funding Round

Series A - Nanopath

Series A - Nanopath

Investment Firm

Overview

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Announced Date

Aug 09, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Norwest Venture Partners

Norwest Venture Partners

Norwest Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and secondary_market and venture firm.

Medtech Convergence Fund

Medtech Convergence Fund

Medtech Convergence Fund is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorGreen D Ventures
Participant InvestorUndeterred Capital
Participant InvestorMedtech Convergence Fund
Participant InvestorNorwest Venture Partners

Round Details and Background

Nanopath raised $10000000 on 2022-08-09 in Series A

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 09, 2022
Series A - Nanopath
6-10.0M
Dec 21, 2021
Grant - Nanopath
2-255.9K
May 21, 2024
Grant - Nanopath
2-4.0M

Recent Activity

There is no recent news or activity for this profile.